Chober, D.; Aksak-Wąs, B.; Bobrek-Lesiakowska, K.; Budny-Finster, A.; Hołda, E.; Mieżyńska-Kurtycz, J.; Jamro, G.; Parczewski, M.
Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study. J. Clin. Med. 2022, 11, 2286.
https://doi.org/10.3390/jcm11092286
AMA Style
Chober D, Aksak-Wąs B, Bobrek-Lesiakowska K, Budny-Finster A, Hołda E, Mieżyńska-Kurtycz J, Jamro G, Parczewski M.
Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study. Journal of Clinical Medicine. 2022; 11(9):2286.
https://doi.org/10.3390/jcm11092286
Chicago/Turabian Style
Chober, Daniel, Bogusz Aksak-Wąs, Katarzyna Bobrek-Lesiakowska, Anna Budny-Finster, Ewa Hołda, Joanna Mieżyńska-Kurtycz, Grzegorz Jamro, and Miłosz Parczewski.
2022. "Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study" Journal of Clinical Medicine 11, no. 9: 2286.
https://doi.org/10.3390/jcm11092286
APA Style
Chober, D., Aksak-Wąs, B., Bobrek-Lesiakowska, K., Budny-Finster, A., Hołda, E., Mieżyńska-Kurtycz, J., Jamro, G., & Parczewski, M.
(2022). Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study. Journal of Clinical Medicine, 11(9), 2286.
https://doi.org/10.3390/jcm11092286
